Free Trial
LON:EAH

ECO Animal Health Group (EAH) Share Price, News & Analysis

GBX 114.64
-1.36 (-1.17%)
(As of 10:49 AM ET)
Today's Range
112.09
117
50-Day Range
115.02
131.50
52-Week Range
82.67
135
Volume
83,176 shs
Average Volume
108,127 shs
Market Capitalization
£77.66 million
P/E Ratio
N/A
Dividend Yield
0.87%
Price Target
N/A
EAH stock logo

About ECO Animal Health Group Stock (LON:EAH)

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

EAH Stock Price History

EAH Stock News Headlines

AI’s Biggest Problem
Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.
Eco Animal Health Group Plc (LSE: EAH)
AI’s Biggest Problem
Nvidia's been quietly pivoting to another, potentially lucrative business. Nvidia's own CEO, Jensen Huang, believes Big Tech is going to spend over $1 trillion on this part of the business over the next four years.
The Big Green List 2024
16 Vinegar Hacks For A Cleaner Kitchen
See More Headlines
Receive EAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ECO Animal Health Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
234
Year Founded
N/A

Profitability

Net Income
£-1,620,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£88.46 million
Cash Flow
GBX 18.94 per share
Book Value
GBX 120 per share

Miscellaneous

Free Float
N/A
Market Cap
£77.66 million
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. David Charles Hallas (Age 60)
    CEO & Director
    Comp: $491k
  • Mr. Christopher Wilks ACA (Age 60)
    BSc, F.C.A., CFO, Finance Director, Secretary & Director
    Comp: $332k

EAH Stock Analysis - Frequently Asked Questions

How have EAH shares performed this year?

ECO Animal Health Group's stock was trading at GBX 108.50 at the beginning of the year. Since then, EAH stock has increased by 5.7% and is now trading at GBX 114.64.
View the best growth stocks for 2024 here
.

How do I buy shares of ECO Animal Health Group?

Shares of EAH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of ECO Animal Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ECO Animal Health Group investors own include Intrepid Potash (IPI), Allena Pharmaceuticals (ALNA), Iovance Biotherapeutics (IOVA), Navios Maritime (NM), Anpario (ANP), Ampliphi Biosciences (APHB) and Actinium Pharmaceuticals (ATNM).

This page (LON:EAH) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners